In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...
A new analysis led by researchers at Washington University School of Medicine in St. Louis has revealed detailed 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal ...
A peer-reviewed Harvard Medical School study recently published in Nature shows how a new artificial intelligence (AI) digital pathology tool called CHIEF (Clinical Histopathology Imaging Evaluation ...
SAN DIEGO, Sept. 2, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today provided an ...
Durable survival in heavily pretreated patients, including those who failed prior immunotherapy and with active liver metastases Signals of tumor agnostic benefit observed Tumor types included CRC, ...
CAMBRIDGE, Mass., Oct. 17, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation & immunology (I&I) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results